open access

Vol 11, Supp. G (2015)
Case report
Published online: 2015-12-17
Get Citation

Treatment targeting somatostatine receptors in disseminated neuroendocrine tumor — case study

Łukasz Hajac

open access

Vol 11, Supp. G (2015)
CASE REPORT
Published online: 2015-12-17

Abstract

Patient age 56 experiencing heartburn and dyspepsia was diagnosed with advanced neuroendocrine tumor via explorative laparotomy. He was treated subsequently with both “hot” (radioactive) and “cold” somatostatine analogues with satisfactory effects — partial control of flush symptom and overall disease stabilization. Following those therapies there was disease progression and classical cytotoxic chemotherapy with 5-fluorouracil, but there were no effect of that type of treatment.

Abstract

Patient age 56 experiencing heartburn and dyspepsia was diagnosed with advanced neuroendocrine tumor via explorative laparotomy. He was treated subsequently with both “hot” (radioactive) and “cold” somatostatine analogues with satisfactory effects — partial control of flush symptom and overall disease stabilization. Following those therapies there was disease progression and classical cytotoxic chemotherapy with 5-fluorouracil, but there were no effect of that type of treatment.

Get Citation

Keywords

neuroendocrine tumor, octreotide, radioisotope therapy

About this article
Title

Treatment targeting somatostatine receptors in disseminated neuroendocrine tumor — case study

Journal

Oncology in Clinical Practice

Issue

Vol 11, Supp. G (2015)

Article type

Case report

Pages

6-8

Published online

2015-12-17

Keywords

neuroendocrine tumor
octreotide
radioisotope therapy

Authors

Łukasz Hajac

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl